Variables | N. (%) and/or Mean ± SD | |||
---|---|---|---|---|
Total population (n. = 29) | Adults (age < 70; n. = 15) | Elderly (age ≥ 70; n. = 14) | p value | |
Age (years) | 67.13 ± 9.96 | 59.84 ± 5.34 | 76.51 ± 5.25 | < 0.001 |
Gender | 0.035 | |||
Male | 21 (72.41) | 8 (53.33) | 13 (92.86) | |
Female | 8 (27.59) | 7 (46.67) | 1 (7.14) | |
ASA | 0.017 | |||
II | 12 (41.38) | 8 (53.33) | 4 (28.57) | |
III | 11 (37.93) | 7 (46.67) | 4 (28.57) | |
IV | 6 (20.69) | 0 (0) | 6 (42.86) | |
Smoker | 13 (44.83) | 7 (46.67) | 6 (42.86) | 0.873 |
Comorbidities | ||||
Hypertension | 20 (68.96) | 10 (66.67) | 10 (71.42) | |
COPD | 10 (34.48) | 2 (13.33) | 8 (57.14) | 0.021 |
Heart disease | 10 (34.48) | 2 (13.33) | 8 (57.14) | 0.021 |
Diabetes | 4 (13.79) | 2 (13.33) | 2 (14.29) | |
SARS-CoV-2 swab positivity | 0 (0) | 0 (0) | 0 (0) | |
Pleural empyema stage | ||||
I | 0 (0) | 0 (0) | 0 (0) | |
II | 29 (100) | 15 (100) | 14 (100) | |
III | 0 (0) | 0 (0) | 0 (0) | |
Affected lung | ||||
Left | 20 (68.97) | 12 (80.00) | 8 (57.14) | |
Right | 9 (31.03) | 3 (20.00) | 6 (42.86) |